What is Abcore?
Abcore specializes in antibody and nanobody solutions, leveraging a proprietary phage display platform for single domain (VHH) antibody discovery. The company offers comprehensive, end-to-end services in antibody discovery and development, alongside custom antibody production. Its operations are centered in San Diego, California, positioning it within a key biotech hub.
How much funding has Abcore raised?
Abcore has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Abcore?
With substantial late-stage capital secured, Abcore is poised for significant scaling and expansion of its nanobody and antibody discovery and development capabilities. This strategic financing is expected to fuel further innovation in proprietary phage display technologies and enhance its custom antibody production services, potentially leading to broader market penetration and new strategic partnerships in the biotechnology sector.
See full Abcore company page
